Nick Leschly
2013 - bluebird bio
In 2013, Nick Leschly earned a total compensation of $2.5M as Chief Executive Officer at bluebird bio, a 311% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $234,000 |
|---|---|
| Option Awards | $1,844,454 |
| Salary | $392,538 |
| Total | $2,470,992 |
Leschly received $1.8M in option awards, accounting for 75% of the total pay in 2013.
Leschly also received $234K in non-equity incentive plan and $392.5K in salary.
Rankings
In 2013, Nick Leschly's compensation ranked 3,164th out of 12,286 executives tracked by ExecPay. In other words, Leschly earned more than 74.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,164 out of 12,286 | 74th |
Division Manufacturing | 1,072 out of 4,612 | 77th |
Major group Chemicals And Allied Products | 279 out of 1,462 | 81st |
Industry group Drugs | 191 out of 1,156 | 84th |
Industry Biological Products, Except Diagnostic Substances | 26 out of 196 | 87th |
Source: SEC filing on April 21, 2016.
Leschly's colleagues
We found three more compensation records of executives who worked with Nick Leschly at bluebird bio in 2013.
News
2seventy bio CEO Nick Leschly's 2023 pay jumps 49% to $9.1M
April 25, 2024
bluebird bio CEO Andrew Obenshain receives $9.3M in 2021
May 2, 2022
2seventy bio CEO Nick Leschly's 2021 pay rises 1% to $6.3M
April 26, 2022
bluebird bio CEO Nick Leschly's 2019 pay falls 45% to $13M
April 27, 2020
bluebird bio CEO Nick Leschly's 2018 pay jumps 173% to $24M
April 23, 2019